{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:16:56Z","timestamp":1791494216064,"version":"4.3.4"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/mnh.0b013e3282f56854","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T03:01:20Z","timestamp":1202871680000},"page":"174-180","source":"Crossref","is-referenced-by-count":100,"title":["Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation"],"prefix":"10.1097","volume":"17","author":[{"given":"Morag J","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210206","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/jcem-6-2-117","article-title":"The general adaptation syndrome and the diseases of adaptation","volume":"6","author":"Selye","year":"1946","journal-title":"J Clin Endocrinol"},{"key":"R2-10-20210206","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J Lab Clin Med"},{"issue":"4t1","key":"R3-10-20210206","first-page":"E657","article-title":"Determinants of cardiac fibrosis in experimental hypermineralocorticoid states","volume":"269","author":"Young","year":"1995","journal-title":"Am J Physiol"},{"issue":"5","key":"R4-10-20210206","first-page":"E883","article-title":"The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis","volume":"271","author":"Young","year":"1996","journal-title":"Am J Physiol"},{"key":"R5-10-20210206","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1210\/en.2002-220926","article-title":"Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"R6-10-20210206","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R7-10-20210206","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1210\/en.2006-0658","article-title":"The role of the glucocorticoid receptor in mineralocorticoid\/salt mediated cardiac fibrosis","volume":"147","author":"Rickard","year":"2006","journal-title":"Endocrinology"},{"key":"R8-10-20210206","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/en.2005-1527","article-title":"Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone\/salt rats","volume":"147","author":"Lam","year":"2006","journal-title":"Endocrinology"},{"key":"R9-10-20210206","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/en.2006-1438","article-title":"Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling?","volume":"148","author":"Fejes-Toth","year":"2007","journal-title":"Endocrinology"},{"key":"R10-10-20210206","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1210\/en.2005-1674","article-title":"Effect of acute aldosterone administration on gene expression profile in the heart","volume":"147","author":"Turchin","year":"2006","journal-title":"Endocrinology"},{"key":"R11-10-20210206","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"R12-10-20210206","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"R13-10-20210206","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.106.670109","article-title":"Added benefit of mineralocorticoid receptor blockade in the primary prevention of sudden cardiac death","volume":"115","author":"Pitt","year":"2007","journal-title":"Circulation"},{"key":"R14-10-20210206","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"New Engl J Med"},{"key":"R15-10-20210206","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"R16-10-20210206","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jacc.2007.03.062","article-title":"Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure","volume":"50","author":"Chan","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R17-10-20210206","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1210\/jc.2007-0393","article-title":"Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus","volume":"92","author":"Joffe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-10-20210206","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"R19-10-20210206","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis","volume":"93","author":"Young","year":"1994","journal-title":"J Clin Invest"},{"issue":"Suppl D","key":"R20-10-20210206","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/eurheartj\/13.suppl_D.24","article-title":"Myocardial collagen matrix remodelling in arterial hypertension","volume":"13","author":"Brilla","year":"1992","journal-title":"Eur Heart J"},{"key":"R21-10-20210206","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"R22-10-20210206","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1210\/en.2004-0005","article-title":"Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone\/salt-treated rats","volume":"145","author":"Young","year":"2004","journal-title":"Endocrinology"},{"key":"R23-10-20210206","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00004872-200405000-00024","article-title":"Tranilast attenuates myocardial fibrosis in association with suppression of monocyte\/macrophage infiltration in DOCA\/salt hypertensive rats","volume":"22","author":"Kagitani","year":"2004","journal-title":"J Hypertens"},{"key":"R24-10-20210206","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/FJC.0b013e318064f150","article-title":"Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte\/macrophage infiltration in the heart of DOCA\/salt hypertensive rats","volume":"50","author":"Ishimaru","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"R25-10-20210206","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.106.646091","article-title":"Critical role of monocyte chemoattractant protein-1\/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy","volume":"115","author":"Frangogiannis","year":"2007","journal-title":"Circulation"},{"key":"R26-10-20210206","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1523-1755.2003.00767.x","article-title":"Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice","volume":"63","author":"Persy","year":"2003","journal-title":"Kidney Int"},{"key":"R27-10-20210206","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.HYP.0000242482.57186.e8","article-title":"Medroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated rats","volume":"48","author":"Arias-Loza","year":"2006","journal-title":"Hypertension"},{"key":"R28-10-20210206","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2005.03.016","article-title":"Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes","volume":"239","author":"Chun","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"R29-10-20210206","first-page":"336","article-title":"Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production","volume":"85","author":"Brown","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-10-20210206","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/snep.2002.34725","article-title":"The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease","volume":"22","author":"Brown","year":"2002","journal-title":"Semin Nephrol"},{"key":"R31-10-20210206","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.CIR.0000097000.51723.6F","article-title":"Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II\/NG-nitro-L-arginine methyl ester-induced myocardial injury","volume":"108","author":"Oestreicher","year":"2003","journal-title":"Circulation"},{"key":"R32-10-20210206","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.ATV.0000152356.85791.52","article-title":"Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II\/salt-induced aortic remodeling","volume":"25","author":"Weisberg","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R33-10-20210206","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/sj.ki.5000201","article-title":"Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury","volume":"69","author":"Ma","year":"2006","journal-title":"Kidney Int"},{"key":"R34-10-20210206","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1160\/TH07-03-0237","article-title":"Acute aldosterone infusion enhances thrombosis development in normotensive rats","volume":"98","author":"Stankiewicz","year":"2007","journal-title":"Thromb Haemost"},{"key":"R35-10-20210206","first-page":"781","article-title":"The determination of mineralocorticoid receptors in human mononuclear leukocytes from patients with mineralocorticoid excess: physiological and pathological implications","volume":"8","author":"Armanini","year":"1986","journal-title":"Clin Exp Hypertens A"},{"key":"R36-10-20210206","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1161\/01.HYP.0000197933.23193.31","article-title":"Mononuclear leukocyte mineralocorticoid receptors. A possible link between aldosterone and atherosclerosis","volume":"47","author":"Armanini","year":"2006","journal-title":"Hypertension"},{"key":"R37-10-20210206","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00005344-200306000-00019","article-title":"Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice","volume":"41","author":"Keidar","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"R38-10-20210206","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.0000184640.81730.22","article-title":"Eplerenone inhibits atherosclerosis in nonhuman primates","volume":"46","author":"Takai","year":"2005","journal-title":"Hypertension"},{"key":"R39-10-20210206","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cardiores.2006.05.001","article-title":"Redox signaling in hypertension","volume":"71","author":"Paravicini","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R40-10-20210206","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20050307","article-title":"Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms","volume":"110","author":"Callera","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"R41-10-20210206","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2005040390","article-title":"Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells","volume":"16","author":"Miyata","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R42-10-20210206","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/en.2006-1691","article-title":"Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling","volume":"148","author":"Stas","year":"2007","journal-title":"Endocrinology"},{"key":"R43-10-20210206","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J"},{"key":"R44-10-20210206","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/01.HYP.0000158845.49943.5e","article-title":"Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase","volume":"45","author":"Touyz","year":"2005","journal-title":"Hypertension"},{"key":"R45-10-20210206","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1089\/ars.2006.8.1473","article-title":"NOX2 and NOX4 mediate proliferative response in endothelial cells","volume":"8","author":"Petry","year":"2006","journal-title":"Antiox Redox Signal"},{"key":"R46-10-20210206","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/ATVBAHA.107.142117","article-title":"Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells","volume":"27","author":"Schroder","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R47-10-20210206","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/01.ATV.0000204344.90301.7c","article-title":"Vascular responses to alpha1-adrenergic receptors in small rat mesenteric arteries depend on mitochondrial reactive oxygen species","volume":"26","author":"Hao","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R48-10-20210206","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"R49-10-20210206","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1006\/jmcc.2000.1159","article-title":"Different regulation of cardiac and renal corticosteroid receptors in aldosterone-salt treated rats: effect of hypertension and glucocorticoids","volume":"32","author":"Silvestre","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"R50-10-20210206","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1291\/hypres.30.427","article-title":"Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in postinfarct rat hearts","volume":"30","author":"Takeda","year":"2007","journal-title":"Hypertens Res"},{"key":"R51-10-20210206","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.HYP.0000088855.06598.5B","article-title":"11beta-hydroxysteroid dehydrogenase type 2 in mouse aorta: localization and influence on response to glucocorticoids","volume":"42","author":"Christy","year":"2003","journal-title":"Hypertension"},{"key":"R52-10-20210206","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1161\/CIRCULATIONAHA.104.503706","article-title":"Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias","volume":"111","author":"Ouvrard-Pascaud","year":"2005","journal-title":"Circulation"},{"key":"R53-10-20210206","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1210\/en.2006-0826","article-title":"Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects","volume":"147","author":"Funder","year":"2006","journal-title":"Endocrinology"},{"issue":"4","key":"R54-10-20210206","first-page":"E649","article-title":"ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"Am J Physiol"},{"key":"R56-10-20210206","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/hc3001.091458","article-title":"Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries","volume":"104","author":"Ward","year":"2001","journal-title":"Circulation"},{"key":"R57-10-20210206","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.steroids.2005.02.004","article-title":"Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system","volume":"70","author":"Mihailidou","year":"2005","journal-title":"Steroids"},{"key":"R58-10-20210206","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.HYP.35.5.1099","article-title":"Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries","volume":"35","author":"Alzamora","year":"2000","journal-title":"Hypertension"},{"key":"R59-10-20210206","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","article-title":"Mineralocorticoid receptors: distribution and activation","volume":"10","author":"Funder","year":"2005","journal-title":"Heart Fail Rev"},{"key":"R60-10-20210206","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1210\/me.2004-0537","article-title":"The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms","volume":"19","author":"Hultman","year":"2005","journal-title":"Mol Endocrinol"},{"key":"R61-10-20210206","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molcel.2005.06.026","article-title":"Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor","volume":"19","author":"Li","year":"2005","journal-title":"Mol Cell"},{"key":"R62-10-20210206","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1128\/MCB.22.11.3698-3706.2002","article-title":"Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex","volume":"22","author":"Kitagawa","year":"2002","journal-title":"Mol Cell Biol"},{"key":"R63-10-20210206","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/me.2004-0331","article-title":"The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions","volume":"19","author":"Pascual-Le Tallec","year":"2005","journal-title":"Mol Endocrinol"},{"key":"R64-10-20210206","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/me.2003-0299","article-title":"Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification","volume":"17","author":"Tallec","year":"2003","journal-title":"Mol Endocrinol"},{"key":"R65-10-20210206","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1096\/fj.06-1202ufm","article-title":"Mechanism-based discovery as an approach to identify the next generation of estrogen receptor modulators","volume":"20","author":"McDonnell","year":"2006","journal-title":"FASEB J"}],"container-title":["Current Opinion in Nephrology & Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNH.0b013e3282f56854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:50:50Z","timestamp":1786035050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041552-200803000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mnh.0b013e3282f56854","relation":{},"ISSN":["1062-4821"],"issn-type":[{"value":"1062-4821","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}